CE vs EMN
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Celanese Corporation exhibits severe fundamental weakness, highlighted by a critical Piotroski F-Score of 2/9, indicating poor financial health. Despite a recent 1-year price recovery, the company is struggling with negative profit margins (-12.21%), a deeply negative ROE (-22.52%), and a high Debt/Equity ratio of 2.89. Revenue and earnings are in sharp decline, with YoY EPS growth collapsing by 88.3%. The disconnect between the bearish deterministic health scores and the 'Buy' analyst consensus suggests a speculative outlook rather than a fundamental one.
Eastman Chemical Company exhibits significant fundamental deterioration, highlighted by a Piotroski F-Score of 4/9 (Stable but weak) and a severe earnings collapse of -67.5% YoY. While the current price of $72.00 sits near the Graham Number ($69.44), it trades at a massive premium to its growth-based intrinsic value of $28.70. The combination of negative revenue growth, a high dividend payout ratio (81.22%), and a bearish technical trend (0/100) suggests the stock is overvalued relative to its current trajectory.
Compare Another Pair
CE vs EMN: Head-to-Head Comparison
This page compares Celanese Corporation (CE) and Eastman Chemical Company (EMN) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.